Content about Impax Labs

May 10, 2011
Impax commences trial for investigational RLS treatment

The branded-drug division of Impax Labs plans to conduct early-stage clinical studies of an investigational drug for restless leg syndrome, the company said Tuesday.

May 9, 2011
Impax confirms patent challenge for generic Concerta

Alza Corp. is attempting to block Impax Labs from developing a generic version of Alza's attention deficit hyperactivity disorder treatment.

April 8, 2011
Impax, Banner to develop two softgel capsule products

Impax Labs will collaborate with a specialty pharmaceutical company dedicated to the research, development and manufacturing of unique gelatin-based dosage forms.

April 5, 2011
Takeda tries to block Impax's launch of generic Dexilant

Generic drug maker Impax Labs is hoping to become the first to market a version of a gastroesophageal reflux disease treatment made by Takeda Pharmaceutical.

March 4, 2011
ReportersNotebook — Chain Pharmacy, 3/14/11

SUPPLIER NEWS — Impax Labs received regulatory approval from the Food and Drug Administration for its generic version of a bacterial infection treatment. The drug maker said the FDA approved its 150-mg doxycycline monohydrate capsules, a drug used to treat bacterial infections and a generic version of Adoxa, made by Nycomed subsidiary PharmaDerm. The 150-mg strength of Adoxa had sales of about $25 million during the 12 months ended in December 2010, according to Wolters Kluwer.

February 18, 2011
Impax granted FDA approval for generic Adoxa

A generic drug maker received regulatory approval from the Food and Drug Administration for its generic version of a bacterial infection treatment.

January 19, 2011
Impax responds to reports about generic Lipitor

In response to articles that appeared in several media outlets about its generic drug pipeline, drug maker Impax Labs is looking to set the record straight.

December 16, 2010
GSK, Impax ink licensing deal for Parkinson's drug

GlaxoSmithKline will pay Impax Pharmaceuticals $11.5 million upfront to exclusively sell Impax's investigational Parkinson’s disease treatment.

December 13, 2010
Shire attempts to block generic Intuniv

Drug maker Shire has filed a patent infringement suit against Watson Pharmaceuticals and Impax Labs in response to their attempt to win approval from the Food and Drug Administration for a generic version of a Shire drug.

November 30, 2010
Impax confirms patent challenge for generic Concerta

A generic version of a drug indicated to treat attention deficit hyperactivity disorder has hit a roadblock.

November 29, 2010
Impax challenges Abbott's Simcor patent

Generic drug maker Impax Labs is challenging the patent covering a drug used to treat high cholesterol, the company said Friday.

November 14, 2010
Countdown to 2011: A big year for generics

The world of generic drugs has a big year ahead of it. Actually, it has...

August 23, 2010
Impax Labs pursuing FDA approval for generic cholesterol-lowering drug

Generic drug maker Impax Labs is hoping to win approval for a generic cholesterol-lowering drug....

July 5, 2010
Impax challenges Renvela patent

Generic drug maker Impax Labs is challenging the patent on a drug used to treat...

June 7, 2010
Endo, Penwest grant Opana ER license to Impax

Endo Pharmaceuticals and Penwest Pharmaceuticals will grant Impax Labs a special license to sell a...

© 2013 Drug Store News. All Rights Reserved.